Cherubim Interests, Inc. (OTC: CHIT) is strategically positioned to realize considerable growth in the months to come, and the company is now making efforts to reward the loyal shareholders who have supported it throughout its transitional phases. As part of these efforts, Cherubim recently announced its inaugural convertible preferred stock dividend, which is intended benefit shareholders of record as of December 31, 2015. Following the cutoff date, the company plans to issue one restricted preferred share of Cherubim Interests for every 100,000 shares held. The company will also issue fractional shares for investors who have purchased less than 100,000 shares.

“This announcement and impending issuance will help those that have seen the dilution in the open market affect their cost average,” Patrick Johnson, chief executive officer of Cherubim, stated in a news release. “Issuing anti-dilutive convertible preferred securities to stockholders as dividends also ensures that they will not be impacted by third-party debt conversions.”

The dividend announcement came just a day after Cherubim signed a memorandum of understanding with United Cannabis Corp. (OTC: CNAB) outlining plans to supply, deploy and provide the technical means to cultivate cannabis. Through subsidiary BudCube Cultivation Systems (BCS), Cherubim will seek to provide the capital investment needed to cover real estate purchases, improvements, construction and deployment for rental locations. After Cherubim delivers, installs and connects the necessary modules to promote cannabis cultivation, CNAB will provide fee-based consulting services on a variety of topics – including standard operating procedures, cultivation, inventory control and management systems, genetics counseling and testing procedures, extract processing and equipment design and proprietary product lines.

By gaining access to CNAB’s existing industry relationships and expertise, Cherubim greatly accelerated its timeline. According to Johnson, the company is now a year or more ahead of its original schedule, and CNAB’s data regarding client servicing is expected to play a key role as Cherubim seeks to promote sustainable growth moving forward.

Cherubim specializes in alternative construction projects by covering the full spectrum of real estate development. The company’s subsidiary, BCS, has developed a fully portable and scalable method of cultivating cannabis, as well as many other plant species, in a diverse range of climate conditions. Cherubim is currently leveraging a unique business model that combines these two fields by developing modular, turn-key cultivation facilities that can be leased to both upstart and established cultivators.

For more information, visit www.cherubiminterests.com

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

Hemp, Inc. CEO Bruce Perlowin was recently was honored with the Jack Herer Cannabis Hemp Award in recognition of Hemp, Inc.’s “Major Achievement in the Hemp Industry.” The awards ceremony was held to not only benefit and bring awareness to the hemp industry, but awareness to the industry in Las Vegas, Nevada.

“We are very proud to have been nominated and to receive this award. On behalf of Hemp, Inc., I would like to thank everyone for every ounce of energy they have put into Jack Herer’s legacy and the continual push of legalizing hemp throughout the United States,” said Perlowin. “It can be difficult to start a company that succeeds in an industry where it is only ‘somewhat legal.’ However, with the help of thousands of people advocating and supporting the hemp industry we are succeeding.”

Producer and co-creator of the Jack Herer Cannabis Awards, Michael Whalen, recognized Perlowin and Hemp, Inc.’s impact on industrial hemp industry with the only commercial industrial hemp decortication facility in the United States. Perlowin was also recognized for shifting the company’s focus toward a more advanced processing in the milling line.

“We were honored to recognize Bruce Perlowin and Hemp, Inc. at the 1st Annual Jack Herer Cannabis Awards on November 28, 2015,” Michael Whalen stated in the news release. “Since this is our first year bringing recognition to some of the leaders and innovators in the cannabis and hemp industries, we kept our awards small … focusing on about seven recipients who we felt really made a difference and who are continuing to pave the way for others as this multi-billion dollar industry unfolds after being suppressed for decades.”

Though Hemp, Inc. will continue to market its hemp-based cosmeceutical and nutraceutical product lines, the legalization of industrial hemp in North Carolina has enabled the company to transition toward a more advanced processing in the milling line.

“In terms of generating profit for the company, our multipurpose industrial hemp processing facility in Spring Hope, North Carolina, will undoubtedly outweigh any sales revenue generated from our product line. This is why we have been full speed ahead with our decortication line which is expected to be fully operational by the second quarter of 2016. It is the only commercial facility in America at this time that will be able to process raw hemp,” said Perlowin.

Hemp, Inc. is also producing lost circulation material (LCM), a much needed resource utilized in the oil and drilling industries. LCM is reportedly hard to source from oversees, and Hemp, Inc. has the capability to provide a local source of better quality LCMs and the means to produce a steady, consistent supply.

For more information, visit www.hempinc.com

Let us hear your thoughts: Hemp, Inc. Message Board

Nutra Pharma Corp., a biotechnology company marketing Nyloxin® and Pet Pain-Away in the over-the-counter (OTC) pain management market, as well as developing treatments for multiple sclerosis (MS), human immunodeficiency virus (HIV), adrenomyeloneuropathy (AMN) and pain, announced today that it has applied for an Orphan Drug designation from the U.S.-FDA for the Company’s RPI-78M drug candidate for the treatment of myasthenia gravis (MG). In September 2015, Nutra Pharma was granted an Orphan Designation for this drug candidate for the treatment of pediatric MS.

“We have been clear over the last year that we would be moving our drug platforms forward,” stated Rik J Deitsch, chairman and CEO of Nutra Pharma. “This includes our work in pediatric multiple sclerosis, as well as additional potential Orphan Designations for our therapeutic pipeline. We expect to receive the Orphan Designation for MG. In the meantime, we will continue to work with our FDA consultants to prepare for an Investigative New Drug Application as we develop the clinical trial protocols for pediatric MS.”

For those unfamiliar with MG, it is a chronic autoimmune neuromuscular disease characterized by varying degrees of weakness of the skeletal (voluntary) muscles of the body. The name “myasthenia gravis” literally means “grave muscle weakness.” MG is known for causing muscle weakness that increases during periods of activity and improves after periods of rest. Certain muscles, such as those that control eye and eyelid movement, facial expression, chewing, talking and swallowing, are often, but not always, involved in the disorder. The muscles that control breathing and neck and limb movements may also be affected. RPI-78M is believed to be effective in the treatment of MG through the modulation of the immune system, preventing autoimmune effects.

By receiving Orphan Drug status, Nutra Pharma would benefit from a seven-year period of market exclusivity in the U.S. upon approval of the drug, as well as tax credits for clinical research costs, the ability to apply for grant funding, clinical trial design assistance, assistance from the FDA in the drug development process, and the waiver of Prescription Drug User Fee Act (PDUFA) filing fees, which could be in excess of $2.5 million. It also allows the company to move forward with its preparation of an Investigative New Drug Application and proposal of clinical trials. The FDA grants Orphan Drug Designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics. The Orphan Drug Act of 1983 is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders, defined as those affecting fewer than 200,000 Americans at any given time.

Originally derived from an extract of cobra venom, RPI-78M is an antagonist of the nicotinic acetylcholine receptor. The drug has an unusually low toxicity with a very large therapeutic window. Scientific publications have shown that native and modified neurotoxins can protect nerve cells from early cell death. Also, RPI-78M may be beneficial in neuromuscular disorders where the activity of nicotinic acetylcholine receptor has been compromised. The proprietary technology is covered by patents describing the application and use of RPI-78M in the treatment of autoimmune diseases.

For additional information about Nutra Pharma, visit www.NutraPharma.com

Let us hear your thoughts: Nutra Pharma Corp. Message Board

TraderPower was established to empower investors with all the resources they need to make profitable trading decisions. Using the vast resources on the TraderPower website, the investment community can discover undervalued small-cap companies, learn how to properly analyze investment opportunities, and utilize free research tools for in-depth evaluation.

TraderPower’s #1 focus is on connecting investors with undervalued small-cap companies that are trading far below their true worth. With an estimated 15,000 publicly traded companies, it’s no surprise that these stocks exist. Of course once these neglected equities begin to get noticed, the climb to their fair valuation can be exceptionally profitable in a very short time.

Want to learn more? Visit www.TraderPower.com and discover your next profitable investment

Let us hear your thoughts below:

Cleantech is a broad term used to describe a diverse range of products, services and processes that utilize renewable materials and energy sources in order to dramatically reduce the use of natural resources and minimize or eliminate harmful emissions and waste. Since coming into the spotlight around the turn of the century, investment in this vital technological sector has grown significantly. In 2007, the United Nations Environment Program reported that wind, solar and biofuel companies received roughly $148 billion in new funding as rising commodity prices and stiffening climate change policies encouraged investment in renewable energy. In a recent article, the Investing News Network placed a spotlight on the future of this pivotal market, particularly as world leaders inch closer to definitive cleantech commitments.

The 2015 United Nations Climate Change Conference, or COP21, is currently underway. Running from November 30 to December 11, the conference is intended to create a roadmap for the meaningful advancement of cleantech in the next 12 months and beyond. COP21 is the culmination of a full year of talks and negotiations between participating countries, and the early results have been promising. Last year, developing countries raised $62 billion to address climate change, putting them on course to reach $100 billion per year by 2020. However, not all progress has been quite so fluid.

A major snag for the world’s largest economies has come in the form of a legally binding accord. While some countries – including Russia and Great Britain – are pushing hard for an accord to enforce strict carbon emissions goals, others – including the United States – refuse to endorse such an agreement. According to Chief U.S. negotiator Todd Stern, legally binding targets “would have many countries unable to participate.” For this reason, it will be imperative for cleantech investors to support national leaders by jumping in and backing the ongoing development of the cleantech industry. The Breakthrough Energy Coalition, led by some of the biggest names in government, business and entrepreneurship, is doing just that.

Launching at the same time as COP21, the Breakthrough Energy Coalition has a mission of creating reliable, affordable and carbon-neutral energy by “developing new tools to power the world.” Led by Bill Gates, the initiative is made up of 28 cleantech investors committed to driving noteworthy progress in the months to come. Among the group are Jeff Bezos, founder and CEO of Amazon (NASDAQ: AMZN); Mark Zuckerburg, founder, chairman and CEO of Facebook (NASDAQ: FB); Marc Benioff, chairman and CEO of Salesforce.com (NYSE: CRM); Reid Hoffman, founder of LinkedIn (NYSE: LNKD); and Jack Ma, executive chairman of Alibaba Group (NYSE: BABA).

For cleantech investors, these two conferences could have a major impact on the performance of the sector in 2016. As big names continue to put their weight behind the industry, those in the space should feel confident moving forward. DreamTeamNetwork outlined its forecast for cleantech in an interview with the Investing News Network. While they anticipate sweeping policy changes at the national level, DreamTeamNetwork also pointed to growing demand for electric vehicles as an area of focus for the cleantech landscape in 2016.

“COP21 should give rise to sweeping new supranational incentivization for further sector growth,” DreamTeamNetwork noted. “Continued emphasis on renewables by China and India, as well as South Africa, the Middle East and Africa, will help to drive the conversation in a new and more open direction.”

To view the full article, visit http://investingnews.com/daily/tech-investing/cleantech-investing/cleantech-investors-2016-outlook

Cherubim Interests has signed a Memorandum of Understanding (MOU) with United Cannabis Corp. (CNAB) under which Cherubim will supply, deploy and provide the technical means to cultivate cannabis.

In exchange, United Cannabis Corp. agrees to provide to BudCube Cultivations Systems fee based consulting services including:

– Standard Operating Procedures
– Cultivation
– Inventory Control and Management Systems
– Genetics Counseling and Testing Procedures
– Extract Processing and Equipment Design, and
– Proprietary Product Line(s)

“We are excited to have Cherubim as a collaborative partner in the construction of cutting-edge laboratory and cultivation facilities. It’s another vital step in accomplishing our mission of providing cannabis based therapies to patients around the world,” stated Earnest Blackmon, CEO of United Cannabis Corp.

The MOU outlines a business model that Cherubim and its BudCube Cultivation Systems (“BCS”) subsidiary are pioneering in the real estate development and medical as well as recreational cannabis cultivation industries. Cherubim will lease modular turn-key cultivation facilities to new and existing market participants in a “mini-storage” or “co-op farming” scenario.

“First, we provide the necessary capital investment to cover any land purchase and improvements, as well as construction and deployment to location for leasing, These portable modules when combined, provide the floor space and square footage required for operations. We then deliver, install and connect the modules while providing standard operating procedures and ongoing maintenance as needed,” Cherubim CEO Patrick J. Johnson explained in the news release.

Though the cannabis/marijuana industry is rapidly growing in terms of public and legislative acceptance, vertical markets, and revenue opportunities, supply is falling short. Addressing this need is where Cherubim plans to lock-in its market position.

“As we see the front of legalization push across States and even into the platforms of the next presidential election, companies are scrambling to catch up. The market is there, the demand is high, but the supply from legal cultivators is low. Cherubim Interests and BudCube are uniquely positioned at this perfect apex of an emerging, billion dollar market; we are positioning ourselves to meet the impending demand by supplying the facility necessary to bring existing as well as start-up companies into full scale production in a matter of months,” said Johnson. “With their existing industry relationships and the services they offer, we believe that our relationship with United Cannabis puts us a year ahead of schedule or quite possible more. We no longer have to reinvent the wheel from a client servicing perspective as United Cannabis has already created that wheel.”

For more information, visit www.cherubiminterests.com

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

Many investors these days are always looking for the next big score. Intense competition and over-saturation of fly-by-night products are major hurdles to overcome when deciding where to invest your hard-earned money. So, you could continue throwing darts at an ‘investment board,’ or you could take the proper amount of time to find and then evaluate a company that has something that is truly unique. One such company is Legacy Ventures International, which has a mission is to acquire businesses with cutting-edge products across a plethora of industries.

Time is the most valuable commodity any of us have, and unfortunately, it is always in short supply. Everyone looking to plan for retirement, invest in good ideas, and reap the profits down the road all have a finite amount of time and resources available to commit to the due diligence process. Fortunately, Legacy Ventures quarterbacks the weeding out process for you; acquires these proven companies; and places them neatly under its conglomerate umbrella. Problem solved. Now, you can get back to spending time with your families, and let the venture capital experts throw touchdown passes for you.

The company has a seasoned executive team and world-renowned advisory board with a vast wealth of experience in investments across the board.

A good comparison case study would be the New England Patriots versus the Dallas Cowboys over the past 15 years. Robert Kraft has been the model of a successful venture capitalist in the NFL whereas Jerry Jones has not. Mr. Kraft has five Super Bowl victories, and Mr. Jones has none. Hiring the right people to run your team, or business, and then, most importantly, letting them do what they are good at instead of micromanaging, firing and making bad decisions in general, is paramount to building a successful franchise, or, in our case, investment.

Warren Buffett is always saying diversification is the key to being a successful investor, so why not take a look at a company whose business model is diversification.

For more information, please visit the company’s website at www.legacyventuresinc.com

Let us hear your thoughts: Legacy Ventures International, Inc. Message Board

Earlier today, GTX Corp, through wholly-owned subsidiary LOCiMOBILE, Inc., announced the launch of its new and improved Track My Workforce (TMWF) app and backend portal. This updated solution allows owners of small and medium sized businesses (SMBs) to better manage their human assets by providing real-time location updates at the touch of a button. Through the TMWF app and portal, GTXO is addressing an expansive market of nearly 30 million SMBs in the United States and roughly 200 million worldwide.

“Real time knowledge has become the norm as more employers want to know where their human assets are during working hours,” Patrick Bertagna, chief executive officer of GTXO, stated in the news release. “Track My Workforce [is] a simple, affordable and easy to deploy tracking product and service.”

In an effort to develop an intuitive, easily scalable product, GTXO engaged LMD Consulting to assist with the design and architecture of the new TMWF app and tracking portal. LMD Consulting has done similar work for an extensive selection of recognizable clients – including Comcast (NASDAQ: CMCSA), Marriott (NASDAQ: MAR) and Louis-Vuitton Moet Hennessy (OTC: LVMUY).

The updated TMWF app and portal is part of GTXO’s ongoing corporate initiative to expand its products and services into new markets and sectors that present a large opportunity to increase market share and bolster the company’s subscription-based recurring revenue model. In the past, the company has had tremendous success in reaching its target audiences with it products. To date, LOCiMOBILE’s suite of consumer apps have been downloaded by more than two million users across 162 countries.

According to a report by the American Management Association, just three percent of employers currently implement GPS monitoring systems on employees’ cell phones and mobile devices. Following the release of the TMWF app and portal, GTXO will look to play a key role in increasing the prevalence of this technology in the coming months. With nearly two-thirds of all Americans currently owning a smartphone, according to Pew Research, the company’s innovative product provides an intuitive, cost-effective solution for employers in a wide range of industries who are seeking to streamline workplace efficiency and limit unnecessary spending.

For more information, visit www.gtxcorp.com

Let us hear your thoughts: GTX Corp. Message Board

International Stem Cell Corp., a California-based biotech developing novel stem cell-based therapies and biomedical products, reports that its Lifeline Skin Care, Inc. subsidiary will launch its next generation skin care product in time for this year’s retail holiday season, which according to research from eMarketer will grow nearly 6% this year.

Starting in mid-December, U.S.-based consumers can purchase Molecular Renewal Serum™ through Lifeline’s website at www.lifelineskincare.com. Following product launches will target the domestic professional sales market such as luxury spas, aestheticians, and medical offices, as well as luxury skincare markets in Europe and Asia.

Molecular Renewal Serum is a collaboration between ISCO’s research and development team, which developed the breakthrough nano-compound technology behind the product, and a renowned cosmetic chemist who formulated the serum.

Independent third-party testing demonstrated that the new skin care product significantly improves skin elasticity and decreases skin roughness in all subjects four and eight weeks after the start of the study. Additionally, the compound-treated group outperformed the baseline as well as the Retinol treated group, without adverse events, such as skin irritation, which has been reported as a common side effect of Retinol treatment.

Lifeline’s current product line includes the Daily Defensive Complex, Recovery Night Moisture Serum, Eye Firming Complex, Dual Action Exfoliator, and Brightening Cleanser. In addition to the Molecular Renewal Serum, in 2015 Lifeline introduced two new products — Refresh Polishing Gelée and Neck Firming Complex.

ISCO’s confidence in Lifeline’s products is validated by professionals in the skin care industry.

Dr. Steven F. Weiner, MD, a facial plastic surgeon and pioneer in the field of minimally invasive cosmetic procedures, stated, “Our office has been using Lifeline Stem Cell Skin products for about four years. We have used it on freshly lasered and microneedled skin without complications and with improved healing times. All of our Infini patients have Lifeline applied and most continue to use it well after treatment because of the noted skin improvements it provides. It’s our best-selling growth factor product because of its higher concentrations of growth factors, streamlined product line and superior results.”

Jill Haynes, a Medical Aesthetician working under Jonathan Sykes, MD, a world renowned pioneer in facial plastic and reconstructive surgery research, at the University of California, Davis Medical Center recommends micro-needling treatments along with Lifeline Skincare products to her patients. “I am seeing incredible results in my patients. This is the biggest skin care breakthrough in years,” she says. “It’s not just about one product or procedure; it’s about using the best products and procedures in conjunction to create noticeable change in the skin.”

Lifeline has established a distribution network with global reach. Products are distributed domestically through the company’s branded website and network of dermatologists, plastic surgeons, and spas. On an international scale, Lifeline products are distributed through a network of local distributors. Shuei Trading Company, Lifeline’s largest international distributor, has introduced currently offered and custom-developed Lifeline products to the Japanese and Hong Kong markets.

Backed by a solid distribution network and growing family of breakthrough products, Lifeline has enjoyed rapid brand and product awareness since its inception five years ago, resulting in steady sales growth and operating income. So far this year, Lifeline has notched $2.6 million in revenue and remains on pace to achieve continued annual growth. Third-quarter revenues equaled $924,000, and the company forecasts even higher fourth-quarter sales.

In 2016, Lifeline plans to continue its upward growth trend with the introduction of several new products based on its proprietary extract and nano-compound technologies.

For more information, visit www.internationalstemcell.com and www.lifelineskincare.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Today before the opening bell, Hemp, Inc. announced that it has become the newest member of one of the most proactive organizations in the industrial hemp industry, the National Hemp Association. In the press release, Hemp, Inc. shared that its gold member status will enable it to reach more hemp businesses with multi-channel exposure. The National Hemp Association (NHA) is a mission-driven, non-profit organization “dedicated to the re-birth of industrial hemp in America which helps connect farmers, processors, manufactures, researchers, investors and policy makers to accelerate the growth of this important industry in the United States.”

NHA also launched a Federal Campaign on Veteran’s Day to legalize industrial hemp on a Federal level. An American hemp flag, made of industrial hemp grown in Kentucky, was flown over the U.S. Capital in Washington, DC to “celebrate the versatile crop cultivated by our founding fathers and calls attention to how hemp can provide a significant source of jobs for veterans and rural farming families.” The Campaign is an effort to “bring hemp back as the major sustainable crop on which our country was founded.” Bruce Perlowin, CEO of Hemp, Inc., has committed to helping the NHA with its goal by encouraging other companies and individuals to support the movement and join the National Hemp Association (NHA).

“It’s time the laws are changed across the board on a Federal level. I want to encourage others to become a Gold member. This will help raise the capital needed to make this campaign a success,” said Perlowin.

To join the National Hemp Association, visit the following link: http://nationalhempassociation.org/membership-has-its-advantages.

According to the NHA’s press release on Nov. 9, 2015, “Once considered America’s most important cash crop, hemp seeds today cannot be transported across state lines and hemp farmers cannot obtain bank accounts or get crop insurance. Industrial hemp is legal in 30 countries around the world. In the U.S., industrial hemp is classified as a Schedule 1 controlled substance (along with narcotics such as heroin and LSD). Advocates hope to restore the industrial hemp industry through passage of the Industrial Hemp Farming Act of 2015 (H.R. 525 and S. 134) which will legally define the difference between hemp and marijuana and will remove hemp from the Controlled Substances Act.”

Perlowin said, “By supporting this campaign and becoming a Gold member, you will not only help to legalize industrial hemp on a federal level, but will receive a host of other benefits as well.” As a Gold member, benefits include but are not limited to: logo listing with active link on NHA’s homepage; logo and clickable link in NHA’s monthly email newsletters; free admission to select NHA events; invitations to pre-qualified Hemp business meetings and opportunities; media referrals; two-hour consultation with NHA Political Director; inclusion in NHA’s press release; eligible to run for the NHA Board of Directors; opportunities to speak at NHA Events; and, a featured story on NHA’s website.

As announced earlier this month, Hemp, Inc. entered into a definitive 5-year term agreement to sell its industrial hemp fiber from its decortication plant in North Carolina to Hemp Blue which will purchase the raw hemp fiber for the production of its hemp denim fabric and manufacture their hemp denim apparel line in the United States all from hemp grown in the United States.

The company’s Kickstarter campaign will run through the end of this week. According to Hemp Blue’s Kickstarter campaign, jeans are not just a pair of pants and hemp is not just another plant. It’s a movement. “A great pair of jeans blends comfort, fashion, good looks, and style with a dash of sex appeal.”

“Hemp Blue, Inc. is a cutting edge and we applaud them for making a prudent economic decision in signing a long-term contract with Hemp, Inc. to assure their supply of American grown hemp for years to come,” said Perlowin. “Support Hemp Blue and Hemp, Inc. by being among the first to own a piece of Hemp Blue’s current collection from their Kickstarter campaign. I also encourage you to purchase Hemp, Inc.’s products at Hempify.us.”

For more information, visit www.hempinc.com

Let us hear your thoughts: Hemp, Inc. Message Board